ASCO expert Chwistek said anti-inflammatory and immune-modulating properties have long suggested broader effects of GLP-1s
By Drug Type: Prescription Dominance Reinforced by Payer Mandates Prescription products represented 64.53% of the anti-obesity drugs market in 2025, and the cohort is on track for a 32.85% CAGR through 2031
These findings were observed in both the intention-to-treat analyses and the on-treatment analyses
For this reason, most peptides studied for systemic effects from BPC-157 to GLP-1 analogs are administered by injection in research and clinical settings
A., Thomsen, M., Kupov, V., Hansen, C
The maximum dose is 12mg once weekly , administered via subcutaneous injection